News | News By Subject | News by Disease News By Date | Search News

Ebola hemorrhagic fever News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Merck & Co. (MRK) Nabs Breakthrough Tag for Ebola Zaire Vaccine From the FDA and PRIME Status From EMA     7/25/2016
Bay Area’s GigaGen Develops Synthetic Immune System to Harness Antibodies     4/19/2016
Did Merck & Co. (MRK) and NewLink Genetics (NLNK) Just Cure Ebola?     8/17/2015
BIO2015 EXCLUSIVE: Private/Public Partnerships Key to Ending Ebola Epidemic Quickly, Says CEO     6/15/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Bill & Melinda Gates Foundation Injects $52 Million Into CureVac     3/9/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
TRICON: Next-Generation Sequencing Can Detect Ebola in Seven Minutes, Raw Data in Under 10     2/18/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola     2/11/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest"     2/10/2015
Chimerix, Inc. (CMRX) Abandons Testing of Experimental Ebola Drug in Liberia     2/3/2015
First Trial Finds GlaxoSmithKline (GSK) Ebola Shot Safe     1/29/2015
GlaxoSmithKline (GSK)'s Long-Awaited Ebola Vaccine Due to Arrive in Liberia     1/26/2015
Johnson & Johnson (JNJ) Lands $115 Million to Speed Up Development of Ebola Vaccine     1/19/2015
Johnson & Johnson (JNJ) Starts Ebola Vaccine Testing in Humans     1/6/2015

News from Around the Web
History Credits This Man With Discovering Ebola On His Own. History Is Wrong     7/14/2016
300 Volunteers Needed To Test "Top Secret" Ebola Vaccine     6/29/2016
Cellphone-Sized Device Quickly Detects The Ebola Virus, Published In American Chemical Society     4/28/2016
Florida International University Researchers Propose Rapid Ebola Test Using Nanotechnology     11/13/2015
Ebola Can Linger in Semen For At Least Nine Months, CDC Reveals     10/15/2015
Chinese Firm Says Plans To "Mass Produce" Ebola Vaccine     10/14/2015
New Genetic Test Speeds Up Ebola Diagnosis, University of California, San Francisco (UCSF) Study     10/2/2015
Chip-Based Technology Enables Reliable Direct Detection Of Ebola Virus, University of California, Santa Cruz (UCSC) Study     9/25/2015
Merck & Co. (MRK)'s Ebola Vaccine Won't Move The Needle     8/24/2015
Rapid Paper-Strip Test For Ebola In Sight, University of Illinois Study     8/19/2015
The New Weapon In The Fight Against Ebola And Other Deadly Pathogens     8/14/2015
Thousands Of Ebola Survivors Face Severe Pain, Possible Blindness     8/10/2015
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
New Tools Deliver Medical Diagnoses, Fast, Cheap And In The Field     6/30/2015
Could An Ebola Treatment Already Exist? Boston University Study     6/15/2015

Press Releases
Biocryst (BCRX) Announces Positive Study Results For BCX4430 Delayed Treatment Of Ebola Virus Infection In A Non-Human Primate Model     9/7/2016
Inovio Pharma (INO) Expands Positive Phase I Ebola Vaccine Trial To Identify Most Optimal Immunization Regimen     8/11/2016
NewLink Genetics (NLNK) Announces Merck & Co. (MRK) Receives Breakthrough Therapy Designation From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine (V920)     7/25/2016
Soligenix (SNGX) Announces Presentation Of Positive Preliminary Results Of A Heat Stable Ebola Vaccine Formulation     7/18/2016
YiSheng BioPharma Reports Early Success For Its Adjuvant In Ebola Vaccine     7/18/2016
YiSheng BioPharma And The United States Army Medical Research Institute Of Infectious Diseases Announce Positive Animal Results Of Vaccine Against Ebola Virus     7/14/2016
Janssen Pharmaceutica N.V. Release: New Idylla Ebola Virus Triage Test Granted Emergency Use Authorization by U.S. FDA     6/1/2016
NewLink Genetics (NLNK) Awarded $21.6 Million Contract Option By BARDA For Ebola Vaccine Development     4/25/2016
EBOVAC1 Release: Global Public-Private Partnership Announces Publication Of Positive Phase 1 Data For Ebola Vaccine Regimen In JAMA     4/19/2016
American Academy of Neurology Release: Most Ebola Survivors Examined In Study Experienced Brain Symptoms Six Months After Infection     2/25/2016
Adimab LLC. Scientists Report The Isolation Of Highly Potent Anti-Ebola Virus Antibodies From Recent Zaire Outbreak     2/19/2016
Gilead (GILD) Announces Fourth Quarter And Full Year 2015 Financial Results     2/3/2016
AbCellera Biologics Announces Successful Completion Of Collaboration For The Discovery Of Fully Human Antibodies Against Pathogenic E. Coli And Ebola Virus     1/21/2016
Profectus BioSciences, Inc. Initiates Ebola Vaccine Phase 1 Clinical Trial     1/19/2016
Albert Einstein College of Medicine Release: Experimental Immunotherapy Zaps Two Most Lethal Ebola Virus Strains     1/13/2016

//-->